News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lipomics Technologies, Inc. to Launch Diagnostic Development Program in Liver Disease


3/17/2008 11:41:26 AM

WEST SACRAMENTO, CA--(Marketwire - March 17, 2008) - Lipomics Technologies, Inc., a privately held company that specializes in developing diagnostics for managing metabolic and cardiovascular disease, announced today that it is launching an effort to validate its proprietary biomarkers for fatty liver disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES